Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA warns on heart failure risk associated with Onglyza, Nesina
FDA warns on heart failure risk associated with Onglyza, Nesina
FDA warns on heart failure risk associated with Onglyza, Nesina
Submitted by
admin
on April 6, 2016 - 10:13pm
Source:
BioPharma Dive
News Tags:
FDA
heart failure
Onglyza
Nesina
AstraZeneca
Takeda
diabetes
Headline:
FDA warns on heart failure risk associated with Onglyza, Nesina
Do Not Allow Advertisers to Use My Personal information
